Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Foghorn Therapeutics Inc. (FHTX) Debt to Equity Ratio data is not available for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$7.56M |
|
$-17.94M |
|
-- |
|
$7.56M |
|
$28.65M |
|
$-21.10M |
|
$3.16M |
|
$-17.94M |
|
$-17.94M |
|
$-17.94M |
|
$-17.94M |
|
$-17.94M |
|
$-17.94M |
|
$-21.10M |
|
$-20.69M |
|
62.98M |
|
62.98M |
|
$-0.28 |
|
$-0.28 |
|
| Balance Sheet Financials | |
$203.84M |
|
$9.51M |
|
$22.39M |
|
$226.24M |
|
$77.79M |
|
-- |
|
$225.11M |
|
$302.89M |
|
$-76.66M |
|
$-76.66M |
|
$-76.66M |
|
55.80M |
|
| Cash Flow Statement Financials | |
$-44.97M |
|
$63.23M |
|
$0.39M |
|
$57.16M |
|
$75.82M |
|
$18.66M |
|
$5.42M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.62 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-- |
100.00% |
|
-279.17% |
|
-279.17% |
|
-- |
|
-237.34% |
|
-237.34% |
|
$-45.02M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
-- |
|
-- |
|
23.40% |
|
23.40% |
|
-7.93% |
|
23.40% |
|
$-1.37 |
|
$-0.71 |
|
$-0.71 |
|